flow cytometry

1:25
Coupling imaging and molecular techniques to determine MRD in MM
Elena Zamagni
1:47
Depth of MRD assessment in MM
Graham Jackson
3:35
Venetoclax: undetectable peripheral blood MRD status as a therapeutic goal in R/R CLL
Sasanka Handunnetti
3:21
Developments in acute leukemias: biology, therapeutics and monitoring
Richard Stone
1:52
MRD by flow cytometry
Giuseppe Gaipa
4:59
Checkpoint Inhibitors in AML
Naval Daver
5:35
Advanced flow cytometry & CAR-T for the treatment of acute leukemias
Giuseppe Gaipa
2:22
Molecular MRD detection in AML
Peter Valk
1:30
The clinical application of MRD testing in AML
Michael Heuser
19:31
Utilizing MRD for AML in the clinical setting
Jorge Sierra et al.
1:27
CyTOF flow cytometry in determining daratumumab response in myeloma
Francesca Gay
1:57
MRD negativity in ALL
Dieter Hoelzer
2:11
Targeted RNA-sequencing for the quantification of MRD in AML
Christopher Hourigan
1:27
MRD detection for AML in China & MFC to detect CEPBA mutations
Hong-Hu Zhu
1:51
Predicting IMiD sensitivity in myeloma
Rafael Fonseca
1:36
Future biomarkers for MDS
Alan List
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals